CCR Prague s.r.o.

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)2 trials
• Psoriasis2 trials
• Ankylosing spondylitis1 trial
• Migraine1 trial

Phase

• Phase 33 trials
• Phase 22 trials
• Phase 41 trial

Status

• Completed6 trials

Lead sponsor

• AbbVie1 trial
• Amgen1 trial
• Amgen Inc.1 trial
• Charite Universitaetsmedizin Berlin KöR1 trial
• DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company1 trial
• and 1 more

Closed trials

• Completed

  Tofacitinib in early active axial spondyloarthritis: a prospective, randomized, double-blind, placebo-controlled multicentre study - FASTLANE

  2023-505050-18-00· Phase 4· Charite Universitaetsmedizin Berlin KöR· Source

• Completed

  A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis

  NCT06073119· Phase 2· Sanofi· Source

• Completed

  Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine

  NCT05748483· Phase 3· AbbVie· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque Psoriasis

  NCT05896527· Phase 2· DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company· Source

• Completed

  A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe AD (ROCKET-Horizon)

  2022-501538-44-00· Phase 3· Amgen Inc.· Source

• Completed

  A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)

  NCT05398445· Phase 3· Amgen· Source